Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
-
Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference
-
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
-
FintechVendors.com Continues Strong Growth as the Market Embraces a Complete Guide to Financial Technology Providers
-
Mosaic Capital Partners Announces Exit of NuSource Financial LLC
-
Quino Energy Closes $10M+$6M in Series A Funding from Atri Energy Transition
-
Crown Fiber Optics Announces $100 Million in Secured Multi-Year Fiber Contracts
-
Esperion Announces New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) in Oral and Poster Presentations at the AHA Scientific Sessions 2025
-
STMicroelectronics announces status of common share repurchase program
-
ASML reports transactions under its current share buyback program
-
Intermap Announces Date for Third Quarter Earnings
-
Goldhale Launches AI-Powered Signal Tool to Enhance Trading Decision Support
-
Datavault AI Files Lawsuit Against Wolfpack Research and Its Founder Dan David
-
Datavault AI Files Lawsuit Against Wolfpack Research and Its Founder Dan David
-
2025 JETOUR Media Alliance Tech Tour Concludes Successfully
-
Black Friday just got bigger: Hostinger raises discounts to help everyone start online
-
BTDUex Global Mainnet Goes Live, Ushering in a New Era of Digital Asset Autonomy
-
rabbitholes.fi Announces Presale on Gempad and Public ICO Dates
-
GenesisCreditRestoration.com Expands Charitable Mission, Offering 100% Free, Full-Service Credit Repair to All
-
Carpenter Technology Corporation Announces Proposed $700.0 Million Private Offering of Senior Notes Due 2034
-
Applied Digital Announces Proposed Offering of $2.35 Billion of Senior Secured Notes
-
Antalpha Reports Third Quarter 2025 Results
-
Surgery Partners, Inc. Announces Third Quarter 2025 Results
-
Tyson Foods Reports Fourth Quarter And Fiscal 2025 Results
-
FreightCar America, Inc. Reports Third Quarter 2025 Results
-
Bluejay Therapeutics’ Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response and up to 82% Combined Endpoint of Virologic Response and ALT Normalization at Week 48 in Phase 2 Study in Chr
-
OneMedNet Delivers on Revenue Model Promise with Palantir-Powered RWD Subscriptions: Live Feeds & AI Search
-
FG Nexus to Present at the 2025 Cantor Crypto & AI/Energy Infrastructure Conference
-
Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
-
IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
-
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
-
InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU)
-
Bakkt Reports Third Quarter 2025 Results
-
OneMedNet Delivers on Revenue Model Promise with Palantir-Powered RWD Subscriptions: Live Feeds & AI Search
-
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
-
SUNation Energy Announces 2025 Third Quarter Results and Reiterates 2025 Full Year Financial Guidance
-
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
-
FG Nexus to Present at the 2025 Cantor Crypto & AI/Energy Infrastructure Conference
-
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
-
IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
-
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Matador Technologies Inc. Announces Closing of Convertible Note Facility to Expand Bitcoin Holdings
-
Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments
-
Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
-
Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
-
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
-
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
-
Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History
-
Wenlay Releases Cross-Chain Bridge Solution to Tackle Multi-Chain Liquidity Challenges
-
Exodus Movement, Inc. Announces Acquisition of Grateful To Strengthen Stablecoin-Based Payments

